Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.

Patients homozygous for the D90A mutation of the SOD1 gene (homD90A) demonstrate markedly slower progression of disease than those patients with sporadic ALS (SALS). PET studies have demonstrated a different cortical vulnerability in the two groups, reflected also in neurophysiological studies showi...

Полное описание

Библиографические подробности
Главные авторы:	Turner, M, Hammers, A, Allsop, J, Al-Chalabi, A, Shaw, C, Brooks, D, Leigh, P, Andersen, P
Формат:	Journal article
Язык:	English
Опубликовано:	2007

Схожие документы

Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET.
по: Turner, M, и др.
Опубликовано: (2007)

Cortical localisation of neuropsychological impairment in amyotrophic lateral sclerosis (ALS): An [C-11] Flumazenil PET study
по: Wicks, P, и др.
Опубликовано: (2005)

Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study.
по: Wicks, P, и др.
Опубликовано: (2008)

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2002)

Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.
по: Turner, M, и др.
Опубликовано: (2005)

Genetics of sporadic amyotrophic lateral sclerosis.
по: Schymick, J, и др.
Опубликовано: (2007)

Diffusion tensor imaging reveals white matter differences between sporadic and familial forms of amyotrophic lateral sclerosis
по: Stanton, B, и др.
Опубликовано: (2008)

Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosis.
по: Stanton, B, и др.
Опубликовано: (2009)

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: Studies with [11C]flumazenil PET
по: Turner, M, и др.
Опубликовано: (2005)

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.
по: Turner, M, и др.
Опубликовано: (2005)

Biomarkers in amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2009)

Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis.
по: Es, V, и др.
Опубликовано: (2009)

Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis.
по: Es, V, и др.
Опубликовано: (2009)

A proposed staging system for amyotrophic lateral sclerosis.
по: Roche, J, и др.
Опубликовано: (2012)

Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis
по: Qian-Qian Wei, и др.
Опубликовано: (2022-01-01)

Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study.
по: Kew, J, и др.
Опубликовано: (1993)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
по: Balendra, R, и др.
Опубликовано: (2015)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
по: Balendra, R, и др.
Опубликовано: (2015)

Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis
по: Fogh, I, и др.
Опубликовано: (2016)

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease
по: Rutter-Locher, Z, и др.
Опубликовано: (2016)

Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
по: Abrahams, S, и др.
Опубликовано: (1997)

Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis
по: A. Panio, и др.
Опубликовано: (2022-05-01)

Amyotrophic lateral sclerosis
по: Leigh P Nigel, и др.
Опубликовано: (2009-02-01)

Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS.
по: Turner, M, и др.
Опубликовано: (2007)

Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
по: Jones, A, и др.
Опубликовано: (2013)

Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
по: Al-Chalabi, A, и др.
Опубликовано: (2003)

REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis
по: Turner, M, и др.
Опубликовано: (2020)

Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis
по: Jennifer A. Fifita, и др.
Опубликовано: (2021-06-01)

Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis.
по: Claudia Figueroa-Romero, и др.
Опубликовано: (2012-01-01)

Targeted exon capture and sequencing in sporadic amyotrophic lateral sclerosis.
по: Julien Couthouis, и др.
Опубликовано: (2014-10-01)

Novel Genetic Signatures Associated With Sporadic Amyotrophic Lateral Sclerosis
по: Robert Logan, и др.
Опубликовано: (2022-03-01)

Cognitive Impairment in Chinese Patients with Sporadic Amyotrophic Lateral Sclerosis.
по: Bo Cui, и др.
Опубликовано: (2015-01-01)

Amyotrophic lateral sclerosis and cerebellum
по: Renata Kabiljo, и др.
Опубликовано: (2022-07-01)

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
по: Jones, A, и др.
Опубликовано: (2014)

Morphological abnormalities in mitochondria of the skin of patients with sporadic amyotrophic lateral sclerosis
по: Gabriel E. Rodríguez, и др.
Опубликовано: (2012-01-01)

Young-onset amyotrophic lateral sclerosis: Historical and other observations
по: Turner, M, и др.
Опубликовано: (2012)

Young-onset amyotrophic lateral sclerosis: historical and other observations.
по: Turner, M, и др.
Опубликовано: (2012)

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
по: Balendra, R, и др.
Опубликовано: (2014)

Quantifying disease progression in amyotrophic lateral sclerosis.
по: Simon, N, и др.
Опубликовано: (2014)

MRI Volumetric Analysis of the Thalamus and Hypothalamus in Amyotrophic Lateral Sclerosis
по: Shan Ye, и др.
Опубликовано: (2022-01-01)